Table 3. Baseline Characteristics of... | American Society of Hematology

Table 3.

Baseline Characteristics of Eligible Patients

Patient Characteristic	N	%
Age (in years)
Median	43
Range	19 to 65
Gender
Male	43	58%
Female	31	42%
Race
White	67	91%
Black	1	1%
Other	6	8%
Performance Status
0	45	61%
1	29	39%
B-Symptoms
Yes	29	40%
No	43	60%
Missing	2
Stage
II	13	18%
III	21	28%
IV	40	54%
Number of Cycles
1 to 5	11	15%
6	39	53%
7	6	8%
8	18	24%
International Index
0 to 1	29	43%
2	29	43%
3	9	13%
4	1	2%
Missing	6
Age Adjusted International Index
0 to 1	37	54%
2	31	46%
Missing	6
Pathology
Follicular large cell	10	14%
Diffuse small cleaved	1	1%
Diffuse mixed	6	8%
Diffuse large cell	37	50%
Large cell immunoblastic	17	23%
Composite	1	1%
Other (Ki-1 anaplastic)	2	3%

Patient Characteristic	N	%
Age (in years)
Median	43
Range	19 to 65
Gender
Male	43	58%
Female	31	42%
Race
White	67	91%
Black	1	1%
Other	6	8%
Performance Status
0	45	61%
1	29	39%
B-Symptoms
Yes	29	40%
No	43	60%
Missing	2
Stage
II	13	18%
III	21	28%
IV	40	54%
Number of Cycles
1 to 5	11	15%
6	39	53%
7	6	8%
8	18	24%
International Index
0 to 1	29	43%
2	29	43%
3	9	13%
4	1	2%
Missing	6
Age Adjusted International Index
0 to 1	37	54%
2	31	46%
Missing	6
Pathology
Follicular large cell	10	14%
Diffuse small cleaved	1	1%
Diffuse mixed	6	8%
Diffuse large cell	37	50%
Large cell immunoblastic	17	23%
Composite	1	1%
Other (Ki-1 anaplastic)	2	3%